Treatment Resistant Depression (TRD)
You May Qualify for the TRD Study If…
• If you are 18 to 65 years of age.
• If you have been struggling with Major Depressive Disorder characterized by persistent feelings of sadness or loss of interest that can lead to a range of behavioral and physical symptoms
• If you are currently in a depressive episode lasting more than 4 weeks
The TRD study is evaluating an investigational medication, in combination with an approved antidepressant, for the treatment of TRD. The investigational medication in this study is approved for use in the United States. It is believed to work via pathways that are markedly different from most currently approved drugs. Doctors believe the combination of the investigational medication and an antidepressant could revolutionize the treatment of depression.
All study-related visits, tests, and drugs may be provided at no cost. In addition, reimbursement for studyrelated travel may be provided.
The study will include approximately 8 visits over approximately 6 weeks with an opportunity to enter an open-label study after completion for approximately 12 months.